HeartSciences Inc.
HeartSciences Inc.
- Market cap
- $8.99M
Your view on HSCS
Overview
What the company does, where it operates, and who runs it.
About HeartSciences Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Andrew Simpson
- Headquarters
- US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Andrew Simpson
- Headquarters
- US
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis.
The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for HeartSciences Inc.. Starting points for HeartSciences Inc.: EPS -$2.80, beta 1.81 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for HeartSciences Inc.. Trailing twelve-month EPS for HeartSciences Inc. stands at -$2.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for HeartSciences Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| FZMDFuse Medical, Inc. | Healthcare | OTC | $3.0M | ||
| GCTKGlucoTrack, Inc. | Healthcare | NASDAQ | $179,582 | ||
| GEHCGE HealthCare Technologies Inc. | Healthcare | NASDAQ | $36.5B | ||
| GGNDFGN Store Nord A/S | Healthcare | OTC | $2.4B | ||
| GKOSGlaukos Corporation | Healthcare | NYSE | $14.0B | ||
| GMEDGlobus Medical, Inc. | Healthcare | NYSE | $8.9B | ||
| GMVDFG Medical Innovations Holdings Ltd | Healthcare | OTC | $25,992 | ||
| GNGBFGetinge AB (publ) | Healthcare | OTC | $5.9B | ||
| GNGBYGetinge AB (publ) | Healthcare | OTC | $6.1B | ||
| GNNDYGN Store Nord A/S | Healthcare | OTC | $2.1B | ||
| GTHPGuided Therapeutics, Inc. | Healthcare | OTC | $25.1M | ||
| HAEHaemonetics Corporation | Healthcare | NYSE | $5.5B | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by HeartSciences Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for HeartSciences Inc.. Coverage tracks HeartSciences Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of HeartSciences Inc.